Dermata Therapeutics, Inc., 2026-01-07
An SEC Form D private-offering notice from San Diego, CA, a $4,124,591 filer-stated offering target in Biotech. Filed 2026-01-07. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotechnology company (Nasdaq: DRMA) developing topical treatments for skin conditions like acne, psoriasis, and rosacea using its Spongilla technology platform.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Prar, Inc., 2026-01-07, $450K, San Francisco, CA
- Matthias Therapeutics, LLC, 2026-01-07, $500K, Basking Ridge, NJ
- Oxide Computer Co, 2026-01-07, $200M, Emeryville, CA
- Fitness Fingerprint Therapeutics, Inc., 2026-01-07, $18.8M, Richmond, VA
- Freeform Future Corp., 2026-01-07, $67.1M, Hawthorne, CA
- Vogenx, Inc., 2026-01-07, $5M, Raleigh, NC
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.